Anthrax: A hidden threat to wildlife in the tropics
(Max-Planck-Gesellschaft) Researchers illuminate the epidemiology of a cryptic pathogen. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 2, 2017 Category: Infectious Diseases Source Type: news
Extended Medical Countermeasure Distribution and Dispensing Considerations for Anthrax Incidents (July 2017)
This document outlines key topics, relevant resources, and current promising practices state and local MCM planners should consider when creating and implementing plans to transition emergency mass dispensing operations from the initial 10-day antibiotic distribution and dispensing effort to distributing and dispensing extended post-exposure prophylactic MCMs. (Source: PHPartners.org)
Source: PHPartners.org - July 27, 2017 Category: International Medicine & Public Health Source Type: news
Emergent BioSolutions acquires GlaxoSmithKline anthrax drug for $96 million
Gaithersburg-based Emergent BioSolutions has been on a bit of a buying spree lately.
On Wednesday, the company announced it would acquire a drug for treating inhaled anthrax from pharmaceutical giant GlaxoSmithKline in an all-cash deal worth up to $96 million.
The deal came less than a week after Emergent (NYSE: EBS) announced it would buy French pharmaceutical giant Sanofi's sma llpox vaccine business in an all-cash deal worth up to $125 million.
"People have been waiting for acquisitions from… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 21, 2017 Category: Pharmaceuticals Authors: Tina Reed Source Type: news
Emergent BioSolutions acquires GlaxoSmithKline anthrax drug for $96 million
Gaithersburg-based Emergent BioSolutions has been on a bit of a buying spree lately.
On Wednesday, the company announced it would acquire a drug for treating inhaled anthrax from pharmaceutical giant GlaxoSmithKline in an all-cash deal worth up to $96 million.
The deal came less than a week after Emergent (NYSE: EBS) announced it would buy French pharmaceutical giant Sanofi's sma llpox vaccine business in an all-cash deal worth up to $125 million.
"People have been waiting for acquisitions from… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 20, 2017 Category: Biotechnology Authors: Tina Reed Source Type: news
Extended Medical Countermeasure Distribution and Dispensing Considerations for Anthrax Incidents
National Association of County and City Health Officials. 05/2017 This 52-page document outlines key topics, relevant resources, and current promising practices that state and local medical countermeasures (MCM) planners should consider when creating and implementing plans to transition emergency mass dispensing operations from the initial 10-day antibiotic distribution and dispensing effort to distributing and dispensing extended post-exposure prophylactic MCMs. It covers a range of distribution and dispensing topics, including maintaining essential functions, inventory management, tracking adverse events, and activation ...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - July 13, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news
Three-Zone Biosecurity Offers New Hope to Indonesian Farmers
James McGrane, FAO ECTAD Indonesia Team Leader, at his office in Jakarta. Credit: Kanis Dursin/IPSBy Kanis DursinJAKARTA, Indonesia, Jul 10 2017 (IPS)Poultry farmer Bambang Sutrisno Setiawan had long heard about biosecurity but never gave serious thought to it, even when the highly pathogenic avian influenza H5N1 forced him to cull thousands of his layer chickens in 2003 and 2009.Eighteen years into the business, however, Bambang, who is called Ilung by friends, is now converting his second farm into a three-zone biosecurity poultry with a strong conviction that it is the only way to save his business amid continued threat...
Source: IPS Inter Press Service - Health - July 10, 2017 Category: International Medicine & Public Health Authors: Kanis Dursin Tags: Asia-Pacific Economy & Trade Featured Food & Agriculture Headlines Health Projects avian flu biosafety Food and Agriculture Organization of the United Nations (FAO) Improving the lives of rural populations: better nutrition & agricultu Source Type: news
26 key bioterrorism jobs the Trump administration has not yet filled
Biological threats pose some of the gravest health risks in our increasingly interconnected world. They can be naturally occurring, such as outbreaks of Ebola infections, or bioterrorism, such as the anthrax attacks in 2001. A study reported this week renews worries about human-made biological agents. Scientists synthesized an extinct horsepox virus closely related to smallpox, the deadliest microbe in human […]Related:Trump administration names Georgia health official as new CDC directorDeaths from cancer higher in rural America, CDC findsHer newborn kept getting sick because she was ingesting placenta, CDC say...
Source: Washington Post: To Your Health - July 7, 2017 Category: Consumer Health News Source Type: news
Recommended Specimens for Microbiology and Pathology for Diagnosis of Anthrax
Centers for Disease Control and Prevention. 01/30/2017 This Web page discusses cutaneous, gastrointestinal, inhalation, injection, and meningeal anthrax that can be diagnosed using a combination of microbiology and pathology testing methods. It makes recommendations about specimens that should be collected for any patient with symptoms compatible with anthrax, with or without a confirmed epidemiological link to a known or high risk exposure. It discusses recommended specimens by clinical presentation, and recommended specimens by specimen type. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - June 21, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news
PBL Gains Approval to Advance Next Generation Anthrax Vaccine
Porton Biopharma Ltd (PBL) has announced that it has signed a modification to its contract with the US National Institute of Health's National Institute of Allergy and Infectious Diseases (NIAID) to advance a next generation intra-nasal anthrax vacci … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 19, 2017 Category: Pharmaceuticals Source Type: news
BioThrax (Anthrax Vaccine Adsorbed Emergent BioSolutions) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 5, 2017 Category: Drugs & Pharmacology Source Type: news
Kenya: Here's How to Prevent Another Anthrax Outbreak in Kenya
[The Conversation Africa] Meat lovers in Thika, north east of Nairobi, are worried. In just one week, eight licensed people who load meat for sale into vans were hospitalised with symptoms similar to anthrax. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 30, 2017 Category: African Health Source Type: news
What Is Anthrax
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 26, 2017 Category: General Medicine Source Type: news
Kenya: Anthrax Patients Discharged From Thika Hospital
[Nation] Seven out of the eight patients who were last week admitted at Thika Level Five hospital bearing symptoms of anthrax have been discharged from the hospital. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 17, 2017 Category: African Health Source Type: news
Kenya: Anthrax Outbreak Confirmed in Makongeni,Thika
[Nation] Thika -A slaughterhouse in Makongeni, Thika has been shut down after six people were admitted at Thika level 5 Hospital following an anthrax outbreak suspected to have emanated from the abattoir. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 12, 2017 Category: African Health Source Type: news
As Ice Melts, Dangerous Diseases From The Past Could Rise Again
The great thing about climate change is that there’s always some new, horrifying consequence to worry about ― like ancient viruses and bacteria emerging from the ice as the Earth warms. Unfortunately, researchers fear we may see more of this in the future.
Some of these viruses and bacteria may have been trapped for millennia, and it’s not even totally clear yet what they are, let alone what kind of damage they might cause.
Researchers have encountered complex “giant viruses” with as many as thousands of genes in the melting permafrost of Siberia. One such virus, 30,000 years old, was still ...
Source: Healthy Living - The Huffington Post - May 5, 2017 Category: Consumer Health News Source Type: news
